Betrixaban scores near miss for extended thromboprophylaxis

Extended thromboprophylaxis with the direct factor Xa inhibitor betrixaban just fails to show superiority to standard treatment with enoxaparin in acutely ill medical patients.

Source: MedWire News - May 31, 2016 Category: Consumer Health News Tags: Thrombosis Source Type: news